Mangoceuticals (MGRX) Return on Capital Employed (2023 - 2025)
Historic Return on Capital Employed for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to 1.08%.
- Mangoceuticals' Return on Capital Employed fell 4300.0% to 1.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.08%, marking a year-over-year decrease of 4300.0%. This contributed to the annual value of 1.17% for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Mangoceuticals' Return on Capital Employed is 1.08%, which was down 4300.0% from 0.69% recorded in Q2 2025.
- In the past 5 years, Mangoceuticals' Return on Capital Employed registered a high of 16.84% during Q1 2024, and its lowest value of 8.29% during Q4 2023.
- In the last 3 years, Mangoceuticals' Return on Capital Employed had a median value of 0.67% in 2024 and averaged 0.44%.
- Per our database at Business Quant, Mangoceuticals' Return on Capital Employed skyrocketed by 77100bps in 2024 and then plummeted by -174500bps in 2025.
- Quarter analysis of 3 years shows Mangoceuticals' Return on Capital Employed stood at 8.29% in 2023, then skyrocketed by 93bps to 0.58% in 2024, then crashed by -85bps to 1.08% in 2025.
- Its last three reported values are 1.08% in Q3 2025, 0.69% for Q2 2025, and 0.61% during Q1 2025.